GSK PLC-SPON ADR (GSK)       28.66  -0.16 (-0.56%)

28.66  -0.16 (-0.56%)

US37733W2044 - ADR - After market: 28.66 0 (0%)

News Image
5 days ago - InvestorPlace

7 Stocks to Buy That Can Soar in Good Times or in Bad

Investors looking for growth stocks to buy that are largely immune from broader economic woes have come to the right place.

News Image
5 days ago - InvestorPlace

Spero Therapeutics (SPRO) Soars 137% on Exclusive License Agreement

Spero Therapeutics (SPRO) stock is rocketing higher on Thursday after the company signed a licensing agreement with GSK (GSK).

News Image
5 days ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time for an overview of the biggest pre-market stock movers for Thursday and all the news behind this morning's movement.

News Image
7 days ago - InvestorPlace

3 Biotech Stocks to Buy Now for Extraordinary Gains

These biotech stocks should deliver big gains to long-term investors who purchase shares at a discount during the bear market.

News Image
a month ago - MarketBeat

Is Sanofi A Buy, Despite Recent Stumbles?

Pharmaceuticals are subject to whiplash trade. That's evident with sharp moves lower in Sanofi, GSK and Teva on news about clinical trials and legal actions.

News Image
a month ago - Investor's Business Daily

Sanofi's Run Of Bad Luck Continues As Pharma Giant Tosses Out A Cancer Drug

Shares extended deep losses following a Zantac-inspired downturn last week.